BRIAN LEVY - Profile, contacts and insights

BRIAN LEVY

Who is BRIAN LEVY?

Clinical stage company developing an orally administered compound to inhibit the dysregulated NLRP3 Inflammasome pathway of autoinflammation. Indications: Diabetic Macular Edema (DME) secondary to Diabetic Retinopathy (DR), Chronic Kidney Disease secondary to Diabetic Nephropathy (DN) and the Geogr...See more

Industry & Specialities

Pharmaceuticals

Manufacturing

Countries of Operation

United States of America

Headquarters:

United States of America

Company Type:

SME

Company size:

1-10 Employees

Year Founded:

2020 (5 years)

Address:

SAN DIEGO, CA 92130, US

The largest company and people database for SEA & ANZ

Employees by Department

The Rest (1)
Total (1)

Key Decision Makers

No Records Found

Employees by Seniority

C-level

0employees

Senior

0employees

Non-managers

0employees

Financials

LOW

spending power

Funding Status

Private

Associated Legal Entities

0 entities

Ready to get started?

Start benefiting from our free-to-use platform today

Discover More Companies

Lookalike companies

Similar industry

Featured Lists

Fast Growing SMEs
Companies with Recent Funding > 100K
Companies with High Spending Power
MNCs / Large Enterprises in Singapore

Frequently Asked Questions (FAQ)

How long has BRIAN LEVY been operating for?
What is the funding status of BRIAN LEVY?
Where is BRIAN LEVY's headquarter?
What BRIAN LEVY's spending power?
Does BRIAN LEVY have a presence in the domain it operates in?

Employees by Department

Key Decision Makers

Financials

Discover More Companies

Lookalike companies

Featured Lists

Frequently Asked Questions (FAQ)

Get in touch